Wealthstream Advisors Inc. Purchases 129 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

Wealthstream Advisors Inc. grew its holdings in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 7.1% during the 4th quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 1,939 shares of the healthcare conglomerate’s stock after acquiring an additional 129 shares during the quarter. Wealthstream Advisors Inc.’s holdings in UnitedHealth Group were worth $981,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds also recently made changes to their positions in UNH. AlphaMark Advisors LLC purchased a new position in UnitedHealth Group during the 4th quarter valued at about $30,000. RPg Family Wealth Advisory LLC bought a new position in UnitedHealth Group in the third quarter worth $37,000. Highline Wealth Partners LLC bought a new position in shares of UnitedHealth Group in the 3rd quarter worth about $55,000. Legacy Investment Solutions LLC bought a new stake in UnitedHealth Group during the third quarter worth about $57,000. Finally, DecisionPoint Financial LLC increased its stake in shares of UnitedHealth Group by 155.0% during the fourth quarter. DecisionPoint Financial LLC now owns 102 shares of the healthcare conglomerate’s stock valued at $52,000 after purchasing an additional 62 shares in the last quarter. Institutional investors own 87.86% of the company’s stock.

UnitedHealth Group Stock Performance

NYSE:UNH opened at $465.58 on Monday. The firm has a market capitalization of $428.46 billion, a PE ratio of 30.04, a P/E/G ratio of 1.37 and a beta of 0.61. UnitedHealth Group Incorporated has a 52-week low of $436.38 and a 52-week high of $630.73. The stock has a 50-day simple moving average of $519.27 and a two-hundred day simple moving average of $560.44. The company has a debt-to-equity ratio of 0.74, a quick ratio of 0.91 and a current ratio of 0.83.

UnitedHealth Group (NYSE:UNH) last posted its quarterly earnings results on Thursday, January 16th. The healthcare conglomerate reported $6.81 EPS for the quarter, beating analysts’ consensus estimates of $6.74 by $0.07. UnitedHealth Group had a return on equity of 26.69% and a net margin of 3.60%. The business had revenue of $100.81 billion for the quarter, compared to analysts’ expectations of $101.60 billion. During the same period last year, the firm earned $5.83 earnings per share. The business’s quarterly revenue was up 6.8% on a year-over-year basis. Analysts forecast that UnitedHealth Group Incorporated will post 29.54 EPS for the current year.

Insider Activity

In other news, Director Timothy Patrick Flynn acquired 1,000 shares of the business’s stock in a transaction dated Friday, January 17th. The stock was purchased at an average price of $511.57 per share, for a total transaction of $511,570.00. Following the completion of the transaction, the director now directly owns 4,500 shares in the company, valued at approximately $2,302,065. This trade represents a 28.57 % increase in their position. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Company insiders own 0.33% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of research analysts recently weighed in on the company. Wells Fargo & Company reduced their price objective on UnitedHealth Group from $694.00 to $660.00 and set an “overweight” rating for the company in a research report on Tuesday, January 28th. StockNews.com raised shares of UnitedHealth Group from a “hold” rating to a “buy” rating in a research report on Thursday, January 23rd. HSBC upgraded shares of UnitedHealth Group from a “hold” rating to a “buy” rating and set a $595.00 target price on the stock in a research note on Friday, January 10th. Barclays cut their target price on UnitedHealth Group from $655.00 to $642.00 and set an “overweight” rating on the stock in a research note on Friday, January 17th. Finally, Deutsche Bank Aktiengesellschaft upped their price target on UnitedHealth Group from $595.00 to $625.00 and gave the company a “buy” rating in a report on Tuesday, December 3rd. One research analyst has rated the stock with a hold rating, twenty have assigned a buy rating and two have assigned a strong buy rating to the company’s stock. According to data from MarketBeat.com, the company presently has an average rating of “Buy” and an average price target of $629.32.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.